Company Filing History:
Years Active: 2025
Title: Cornelia Haag-Molkenteller: Innovator in Overactive Bladder Treatment
Introduction
Cornelia Haag-Molkenteller is a prominent inventor based in Irvine, CA (US). She has made significant contributions to the field of medicine, particularly in the treatment of overactive bladder symptoms. Her innovative approach has led to the development of a patented method that addresses a common issue faced by many individuals.
Latest Patents
Cornelia holds a patent for Vibegron, which is aimed at treating overactive bladder symptoms in men with benign prostatic hyperplasia. The patent details a method of orally administering an amount of Vibegron ranging from about 60 mg to about 90 mg per day, with a recommended dosage of approximately 75 mg. This advancement represents a crucial step in improving the quality of life for those affected by this condition.
Career Highlights
Throughout her career, Cornelia has demonstrated a commitment to innovation and excellence in her field. She is currently associated with Urovant Sciences GmbH, where she continues to work on developing effective treatments for urological conditions. Her expertise and dedication have positioned her as a key figure in medical research and development.
Collaborations
Cornelia collaborates with esteemed colleagues, including Paul N Mudd, Jr. and Jihao Zhou. These partnerships enhance her research efforts and contribute to the advancement of medical treatments.
Conclusion
Cornelia Haag-Molkenteller's work in the development of Vibegron showcases her dedication to improving patient care in urology. Her innovative spirit and collaborative efforts continue to drive advancements in the treatment of overactive bladder symptoms.